Excelsius’ robotic system helps with navigation, as well as implant sizing, positioning and placement.
Financial terms of the deal were not disclosed, but Globus is expected to obtain the robotic system’s FDA clearance by 2015 with the sale finalizing in 2016.
More Articles on Devices:
Biomet Recovers From Previous Losses, Reports $4.9M Income in Q2
Where the Spine Device Field is Headed: Q&A With Invibio’s Michael Veldman
Stryker, NeuroLogica Enter Exclusive Partnership Agreement to Better Facilitate Image-Guided Surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
